Praxis Precision Medicines (PRAX) Return on Sales: 2023-2025
Historic Return on Sales for Praxis Precision Medicines (PRAX) over the last 2 years, with Sep 2025 value amounting to -13.17%.
- Praxis Precision Medicines' Return on Sales rose 8902.00% to -13.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -13.17%, marking a year-over-year increase of 8902.00%. This contributed to the annual value of -23.40% for FY2024, which is 2824.00% up from last year.
- Per Praxis Precision Medicines' latest filing, its Return on Sales stood at -13.17% for Q3 2025, which was up 12.06% from -14.97% recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Return on Sales high stood at -13.17% for Q3 2025, and its period low was -102.19% during Q3 2024.
- For the 3-year period, Praxis Precision Medicines' Return on Sales averaged around -44.60%, with its median value being -37.52% (2024).
- Data for Praxis Precision Medicines' Return on Sales shows a peak YoY skyrocketed of 8,902bps (in 2025) over the last 5 years.
- Praxis Precision Medicines' Return on Sales (Quarterly) stood at -51.64% in 2023, then soared by 2,824bps to -23.40% in 2024, then skyrocketed by 8,902bps to -13.17% in 2025.
- Its last three reported values are -13.17% in Q3 2025, -14.97% for Q2 2025, and -17.19% during Q1 2025.